10-Q

Company

Aclaris Therapeutics, Inc.

Filed

May 7, 2024

Period of Report

March 31, 2024

Accession Number

0001558370-24-007069

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →